The Preterm Infants' Paracetamol Study

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.

Also called NCT01938261

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
University of Oulu (from the registry)
Registry
  • NCT NCT01938261
  • EudraCT 2013-001842-33
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Finland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01938261. Randomized; quadruple masking; primary purpose prevention. Start 2013-08 (actual); primary completion 2024-07-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Preterm Infants' Paracetamol Study
Acronym
PreParaS
Condition
Persistent Ductus Arteriosus
Condition
Complication of Prematurity
Condition
Pain or Discomfort in Intensive Care of Preterm Infants
Intervention (Drug)
paracetamol
Intervention (Drug)
0.45 % saline solution
Lead sponsor
University of Oulu (class: other)

Record details

Record id
cardio:ct-nct01938261
Content hash
5fcd7ae098ea2b135790389a39ff6179a3af10bf752688e65a1b8c00f03d2c6c